ESM Website Banners (1).png

Education Webinars

The ESM board is pleased to launch a series of Education Webinars to connect and stay in touch with our membership, as so many events have been postponed or cancelled as a result of the COVID19 crisis. The webinars are organised by ESM thanks to a generous contribution from BD and Qiagen, who have not had any influence on content of the presentations. We thank BD and Qiagen very much for their continuous support of our society.

Series 2: October 2021-January 2022

QLogo_30mm_4c_Full resolution_24876.jpeg

Biomarkers for incipient TB and disease progression and cure: today, tomorrow and future

Alberto Matteelli, University of Brescia and Brescia Spedali Civili General Hospital
Morten Ruhwald, FIND, Geneva

Unmet needs in screening for TB infection in high incidence/low resource settings: new tools and approaches.

Lele Rangaka, University College London

Series 2: May-June 2021

bd.jpg

Sampling, Ordering and Logistics – the Keys of good TB diagnostics:

How to choose and collect the best TB samples and how to optimize ordering, reporting and transportation with the help of smart software solutions.

Harald Hoffmann, IML Red, Gautling Germany
Simon Tiberi, Barts Health NHS Trust, London

NTM (non-tuberculosis mycobacteria) Pulmonary disease, from diagnosis to treatment

Jakko van Ingen, RaboudUMC, Nijmegen

Three European healthcare system perspectives on TB diagnostics: setup and challenges in different settings

Florian Maurer, National Reference

Center for Mycobacteria, Borstel
Troels Lillebaek, Statens Serum Institut, Copenhagen
Natalia Shubladze, National Center for TB and Lung Diseases of Georgia

Series 1: September 2020

bd.jpg
ESM_YouTube Thumbnail.jpg

Role and value of NGS in TB diagnostic and clinical management: today, tomorrow and long-term

Vlad Nikolayevskyy, National Mycobacterum Reference Service South, Public Health England, London

Watch video (you will need to be logged into your ESM online account to view).

M. tuberculosis drug susceptibility testing: Genotypic vs Phenotypic approaches: What and How, Advantages and Limitations 

Leen Rigouts, Institute of Tropical Medicine, Antwerp
Stefan Niemann, National Reference Center for Mycobacteria Forschungszentrum, Borstel

Drug susceptibility testing and treatment of NTM disease. 

Jakko van Ingen, RaboudUMC, Nijmegen